A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA).

Trial Profile

A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA).

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs Atorvastatin; Niacin; Simvastatin
  • Indications Atherosclerosis
  • Focus Biomarker; Pharmacogenomic; Therapeutic Use
  • Acronyms MCAT
  • Sponsors Merck & Co
  • Most Recent Events

    • 23 Oct 2012 Planned number of patients changed from 100 to 138.
    • 18 Apr 2012 Actual patient number changed from 96 to 100 as reported by ClinicalTrials.gov.
    • 12 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top